文献速递胸部肿瘤

致癌驱动非小细胞肺癌中PD-L2表达的内在与外在调控

Intrinsic and Extrinsic Regulation of PD-L2 Expression in Oncogene-Driven Non-Small Cell Lung Cancer.
PubMed 文献 · J Thorac Oncol · 2018-03-27

该研究探讨非小细胞肺癌(NSCLC)中PD-L2表达的内在与外在调控机制。结果显示,活化EGFR突变或EML4-ALK融合内在诱导PD-L2表达,而IFN-γ通过STAT1信号外在诱导PD-L2表达,STAT3和c-FOS可能参与两种途径。

要点

  • 活化EGFR突变或EML4-ALK融合可内在诱导NSCLC细胞PD-L2表达。
  • 相应TKI或siRNA敲低EGFR/ALK可抑制PD-L2表达。
  • IFN-γ通过STAT1信号外在诱导PD-L2表达。

核心结论

  • PD-L2表达由活化EGFR突变或EML4-ALK融合内在诱导,并由IFN-γ外在诱导。
  • STAT3和c-FOS可能同时参与内在和外在诱导PD-L2表达的途径。

研究设计与样本

  • 实验研究,使用BEAS-2B细胞稳定表达活化EGFR突变体或EML4-ALK融合蛋白。
  • 使用携带相应驱动癌基因的NSCLC细胞系,通过RT-PCR和流式细胞术评估PD-L2表达。

主要发现

  • 稳定表达活化EGFR突变体或EML4-ALK融合蛋白的BEAS-2B细胞在mRNA和蛋白水平PD-L2表达增加。
  • 携带驱动癌基因的NSCLC细胞系经相应EGFR或ALK TKI处理或siRNA敲低EGFR/ALK后PD-L2表达受抑。
  • IFN-γ通过STAT1信号在NSCLC细胞中诱导PD-L2表达。
  • 敲低STAT3或c-FOS可抑制NSCLC细胞中癌基因驱动的PD-L2表达。
  • IFN-γ也激活STAT3和c-FOS。

临床怎么用

  • 携带活化EGFR突变或EML4-ALK融合的NSCLC可能内在高表达PD-L2,TKI治疗可能下调其表达。
  • IFN-γ可外在诱导PD-L2表达,提示免疫微环境可能影响PD-L2水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The interaction of programmed cell death ligand 2 (PD-L2) with programmed cell death 1 is implicated in tumor immune escape. The regulation of PD-L2 expression in tumor cells has remained unclear, however. We here examined intrinsic and extrinsic regulation of PD-L2 expression in NSCLC. METHODS: PD-L2 expression was evaluated by reverse transcription and real-time polymerase chain reaction analysis and by flow cytometry. RESULTS: BEAS-2B cells stably expressing an activated mutant form of EGFR or the echinoderm microtubule associated protein like 4 (EML4)-ALK receptor tyrosine kinase fusion oncoprotein manifested increased expression of PD-L2 at both the mRNA and protein levels. Furthermore, treatment of NSCLC cell lines that harbor such driver oncogenes with corresponding EGFR or ALK tyrosine kinase inhibitors or depletion of EGFR or ALK by small interfering RNA transfection suppressed expression of PD-L2, demonstrating that activating EGFR mutations or echinoderm microtubule associated protein like 4 gene (EML4)-ALK receptor tyrosine kinase gene (ALK) fusion intrinsically induce PD-L2 expression. We also found that interferon gamma (IFN-γ) extrinsically induced expression of PD-L2 through signal transducer and activator of transcription 1 signaling in NSCLC cells. Oncogene-driven expression of PD-L2 in NSCLC cells was inhibited by knockdown of the transcription factors signal transducer and activator of transcription 3 (STAT3) or c-FOS. IFN-γ also activated STAT3 and c-FOS, suggesting that these proteins may also contribute to the extrinsic induction of PD-L2 expression. CONCLUSIONS: Expression of PD-L2 is induced intrinsically by activating EGFR mutations or EML4-ALK fusion and extrinsically by IFN-γ, with STAT3 and c-FOS possibly contributing to both intrinsic and extrinsic pathways. Our results thus provide insight into the complexity of tumor immune escape in NSCLC.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Shibahara D, Tanaka K, Iwama E, et al. Intrinsic and Extrinsic Regulation of PD-L2 Expression in Oncogene-Driven Non-Small Cell Lung Cancer. J Thorac Oncol. 2018. PMID: 29596910. doi:10.1016/j.jtho.2018.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。